DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Lasa Supergenerics Limited — Cessation

NSE 25 Aug·25 Aug 2026, 10:58 am

Lasa Supergenerics

Lasa Supergenerics Limited has announced that Mr. Ganesh has stepped down as its Executive Director, effective August 25, 2026. This change marks a shift in the company's senior leadership structure.

For investors, this development is noteworthy as it signals a potential transition in the company's strategic direction or operational oversight. While the resignation itself is not uncommon, it warrants attention to understand the reasons behind the change and the impact on the company's future governance.

Investors should monitor the company's official filings for any further details regarding the appointment of a successor and the rationale behind this leadership change.